Hydrocephalus and intestinal aganglionosis: Is L1CAM a modifier gene in Hirschsprung disease?

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8628|108|1|51-56

ISSN： 0148-7299

Source： American Journal of Medical Genetics, Vol.108, Iss.1, 2002-02, pp. : 51-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modifier Gene Studies to Identify New Therapeutic Targets in Cystic Fibrosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 5, 2012-02 ,pp. : 674-682

Bentham Science Publishers

Access to resources Recommend Favorite

Yellow fever vaccine: Neurotropic disease in an elderly patient with hydrocephalus: case report

By  

Reactions Weekly, Vol. 1, Iss. 1291, 2010-01 ,pp. : 45-45

Adis International

Access to resources Recommend Favorite

Management of intestinal obstruction in malignant disease

By Hirst Becky   Regnard Claude  

Clinical Medicine, Vol. 3, Iss. 4, 2003-07 ,pp. : 311-314

Royal College Of Physicians

Access to resources Recommend Favorite

Melatonin, Autophagy and Intestinal Bowel Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4816-4827

Bentham Science Publishers

Access to resources Recommend Favorite

Active oligonucleotides incorporating alkylating an agent as potential sequence- and base selective modifier of gene expression

By Sasaki S.  

European Journal of Pharmaceutical Sciences, Vol. 13, Iss. 1, 2001-04 ,pp. : 43-51

Elsevier

Access to resources Recommend Favorite